Varian Medical Systems (VAR) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017
April 26, 2017 4:02 PM EDTPALO ALTO, Calif., April 26, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting GAAP net earnings from continuing operations of $0.74 per diluted share and non-GAAP net earnings from continuing operations of $0.89 per diluted share for the second quarter of fiscal year 2017. Varian's second quarter revenues from continuing operations totaled $655 million, up 6 percent from the year-ago quarter in dollars and 7 percent in constant currency. The company ended the quarter with a $3.1 billion backlog, up 4 percent from the same point in fiscal year 2016, with a 6 percent gain in the Oncology Systems backlog.
... More